A pilot study of chronic, low-dose epoetin-β following percutaneous coronary intervention suggests safety, feasibility, and efficacy in patients with symptomatic ischaemic heart failure

A single dose of erythropoietin in ST-elevation myocardial infarction

(2010) A. A. Voors et al.   EUROPEAN HEART JOURNAL

Should erythropoietin treatment in chronic heart failure be haemoglobin targeted?

(2010) Lennaert Kleijn et al.   EUROPEAN JOURNAL OF HEART FAILURE

Differential Mobilization of Subsets of Progenitor Cells from the Bone Marrow

(2009) Simon C. Pitchford et al.   Cell Stem Cell

Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial

(2009) Michał Tendera et al.   EUROPEAN HEART JOURNAL

Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial

(2009) John J.V. McMurray et al.   EUROPEAN JOURNAL OF HEART FAILURE

A secondary analysis of the CHOIR trial shows that comorbid conditions differentially affect outcomes during anemia treatment

(2009) Lynda A. Szczech et al.   KIDNEY INTERNATIONAL

Single high-dose intramyocardial administration of erythropoietin promotes early intracardiac proliferation, proves safety and restores cardiac performance after myocardial infarction in rats☆

(2009) Ralf Gäbel et al.   Interactive Cardiovascular and Thoracic Surgery

Chronic Erythropoietin Treatment Decreases Post-Infarct Myocardial Damage in Rats without Venous Thrombogenic Effect

(2008) F. Prunier et al.   CARDIOLOGY

Erythropoietin Stimulates Normal Endothelial Progenitor Cell-Mediated Endothelial Turnover, but Attributes to Neovascularization Only in the Presence of Local Ischemia

(2008) B. Daan Westenbrink et al.   CARDIOVASCULAR DRUGS AND THERAPY

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)

(2008) et al.   EUROPEAN HEART JOURNAL

Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit

(2008) Erik Lipšic et al.   EUROPEAN JOURNAL OF HEART FAILURE

The Potential Role of Erythropoietin in Chronic Heart Failure: From the Correction of Anemia to Improved Perfusion and Reduced Apoptosis?

(2008) Stefan A.J. Timmer et al.   JOURNAL OF CARDIAC FAILURE

Stem Cell Mobilization by Granulocyte Colony-Stimulating Factor for Myocardial Recovery After Acute Myocardial Infarction

(2008) Dietlind Zohlnhöfer et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY